Sophie Caillard
Overview
Explore the profile of Sophie Caillard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
3221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benotmane I, Kasriel N, Masset C, Michard B, Malvezzi P, Giguet B, et al.
Transplantation
. 2025 Jan;
PMID: 39883018
Background: It remains unclear whether physicians should accept transplantation offers for candidates with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test due to the potential risk of severe infection...
2.
Beaudrey T, Apithy M, Olagne J, Lemonnier L, Perrin P, Vargas G, et al.
Hum Immunol
. 2025 Jan;
86(2):111213.
PMID: 39826255
Imlifidase is an endopeptidase known for cleaving anti-Human Leucocyte Antigen donor-specific antibodies (DSA) to allow high-risk kidney transplantation. However, it lacks comprehensive data regarding its effect on alloantibodies targeting other...
3.
Garrouste C, Poirier P, Uro-Coste C, Iriart X, Kamar N, Bonhomme J, et al.
Transpl Int
. 2024 Dec;
37:13518.
PMID: 39726674
Trial Registration Number: ClinicalTrials.gov ID: NCT05417815.
4.
Espi M, Charmetant X, Benotmane I, Lefsihane K, Barateau V, Gallais F, et al.
J Med Virol
. 2024 Nov;
96(11):e70037.
PMID: 39530340
Kidney transplant recipients (KTRs) are highly vulnerable to COVID-19. An intensified scheme of vaccination offers short-term protection to the 50%-75% of KTRs able to develop a germinal center reaction, required...
5.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, et al.
Kidney Int
. 2024 Nov;
107(2):338-347.
PMID: 39490986
The MTOR inhibitors have demonstrated antiviral properties, and prior non-randomized studies have suggested they may have a suppressive effect on BKPyV replication. Here, in this randomized, multicenter, controlled trial (BKEVER...
6.
Kamar N, Bertrand D, Caillard S, Pievani D, Apithy M, Congy-Jolivet N, et al.
Kidney Int Rep
. 2024 Oct;
9(10):2927-2936.
PMID: 39430184
Introduction: Imlifidase is authorized for desensitization of highly sensitized adult kidney transplant candidates with a positive crossmatch (XM) against a deceased donor. Here, we report on the results for the...
7.
Ould Rabah M, Morin L, Dali-Youcef N, Geri G, Mazloum M, Garcelon N, et al.
Kidney360
. 2024 Oct;
5(12):1902-1912.
PMID: 39382974
No abstract available.
8.
Maanaoui M, Lenain R, Foucher Y, Buron F, Blancho G, Antoine C, et al.
Lancet Diabetes Endocrinol
. 2024 Sep;
12(10):716-724.
PMID: 39250921
Background: Islet transplantation has been associated with better metabolic control and quality of life than insulin treatment alone, but direct evidence of its effect on hard clinical endpoints is scarce....
9.
Benotmane I, Jungbauer-Groznica M, Staropoli I, Planas D, Dehan O, Brisebarre A, et al.
Transpl Int
. 2024 Jul;
37:13272.
PMID: 39081903
No abstract available.
10.
Bertrand D, Gatault P, Jaureguy M, Garrouste C, Duveau A, Bouvier N, et al.
Transplantation
. 2024 Jul;
108(8):e204-e206.
PMID: 39042372
No abstract available.